CN109085336A - A kind of immune chromatography test paper detecting fumonisins B1 - Google Patents
A kind of immune chromatography test paper detecting fumonisins B1 Download PDFInfo
- Publication number
- CN109085336A CN109085336A CN201810992495.9A CN201810992495A CN109085336A CN 109085336 A CN109085336 A CN 109085336A CN 201810992495 A CN201810992495 A CN 201810992495A CN 109085336 A CN109085336 A CN 109085336A
- Authority
- CN
- China
- Prior art keywords
- solution
- added
- label
- room temperature
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a kind of immune chromatography test papers for detecting fumonisins B1, the test paper includes supporter and the adsorption layer that is fixed on supporter, adsorption layer is followed successively by sample pad, bonding pad, chromatographic film and absorption pad since test lead, and the anti-FB1 monoclonal antibody of nano material label is adsorbed on the bonding pad；The stealthy control trace that the chromatographic film is equipped with the stealthy detection trace printed with FB1 artificial antigen solution and is printed with goat-anti or rabbit anti-mouse IgG antibody solution；The nano material is nitrogen-doped carbon nano material, carbon nanomaterial, carbon quantum dot fluorescent nano particle.Test strips of the invention have the characteristics that high specificity, high sensitivity, stability are high, safety is good, easy, quick, vivid, intuitive, applied widely, easy to carry as the result is shown and can quantify.It is extremely important in terms of ensuring food safety, protecting consumer health, will have apparent economic benefit and social benefit.
Description
Technical field
The present invention relates to a kind of immune chromatography test papers, more particularly to a kind of immune layer for detecting fumonisins B1 (FB1)
Analyse test paper.
Background technique
The toxin that fumonisins B1 (Fumonisin, FB1) is mainly generated by fusarium moniliforme and many births sickle-like bacteria, the poison
Element is widely present in various grains and its product, especially corn.Fumonisin sterling is white, needle-shaped crystals, for a kind of phase
The polarity of pass, water soluble metabolites are the diester compound of the pure and mild tricarballylic acid of more hydrogen, very stable to heat, are not easy to be cooked
It destroys, it is more stable in most grain processing treatment processes.Fumonisins is not only a kind of rush cancer object, Er Qieshi to people, animal
A kind of carcinogenic substance.Animal experiment and epidemiologic data can cause Ma Naobai it has been shown that fumonisins major determinant hepatic and renal function
Matter malacosis and pig pulmonary edema etc., and it is related with the high-incidence cancer of the esophagus in China and South Africa some areas, cause world wide
Extensive attention.But it is domestic at present not clear for fumonisins harm to the human body concrete condition.
Mainly there are biological detection method, chemical analysis, instrumental method for the detection method of FB1 both at home and abroad at present and exempt from
4 major class of epidemic disease analytic approach.It is very pure that the advantages of biological detection method, is that measuring samples are not required to, the disadvantage is that sensitivity is low, experimental period is longer.
The advantages of chemical analysis is economical and practical, but is unable to accurate quantitative analysis, and the repeatable and reproducibility for analyzing result is poor.Instrument
Analytic approach has high score from advantages such as, high detection efficiency and quick analysis ability, but pre-treatment to sample and operator
Technical requirements are high, and instrument and equipment is expensive, is unsuitable for field quick detection.Immunoassay is easy to operate, at low cost, knot
Nitrogen-doped carbon nano material marker is closed with excitation-emission length flexible is adjustable, fluorescent stability is high and flicker free phenomenon etc. is excellent
Gesture, final that high sensitive, high stable live rapid quantitative detection can be achieved, society and economic significance are great.
Summary of the invention
Technical problem to be solved by the invention is to provide it is a kind of detect fumonisins B1 (FB1) immune chromatography test paper,
The test paper has the characteristics that special, sensitive, quick, easy.
To achieve the goals above, the technical scheme adopted by the invention is that:
A kind of immune chromatography test paper detecting fumonisins B1, including supporter and the adsorption layer that is fixed on supporter,
Adsorption layer is followed successively by sample pad, bonding pad, chromatographic film and absorption pad since test lead, is adsorbed with nanometer on the bonding pad
The anti-FB1 monoclonal antibody of material marking；The chromatographic film is equipped with the stealthy detection print printed with FB1 artificial antigen solution
Mark and the stealthy control trace printed with goat-anti or rabbit anti-mouse IgG antibody solution；The nano material is received for nitrogen-doped carbon
Rice material, carbon nanomaterial, carbon quantum dot fluorescent nano particle.
Supporter includes the bottom that adsorption layer bottom surface is arranged in and the surface layer that adsorption layer top surface is arranged in.
Nitrogen-doped carbon nano material N-CDs is using chitosan as carbon source, and ethylenediamine is nitrogen dopant, is prepared using hydro-thermal method
It forms, method particularly includes: chitosan 2.5g is dissolved in 5mL ultrapure water, 5mL ethylenediamine is added, mixing is placed on reaction under high pressure
In the polytetrafluoroethylliner liner of kettle, 180 DEG C of reaction 2h after reaction filter product, and distilled water washs 2 times, 60 DEG C of baking ovens
It is dried to obtain N-CDs.
Nitrogen-doped carbon nano material label anti-FB1 monoclonal antibody the preparation method comprises the following steps:
(1) surface carboxylation SiO2The preparation of nano particle
SiO is synthesized using reverse microemulsion method2Nano particle: by volume 10:30:10:1 ratio take Ttiton X-100,
Hexamethylene, n-hexyl alcohol, ultrapure water stir to form 5.1mL microemulsion, after 200 μ L ammonium hydroxide of addition stir evenly, add the 80 positive silicic acid of μ L
Ethyl ester, room temperature are protected from light for 24 hours；6000rpm is centrifuged 10min after reaction, is redissolved after ethanol washing 4 times with 1mL ethyl alcohol, shape
At solution A；0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution B；By solution A plus
Enter into solution B, reaction 70min is stirred at room temperature；After reaction, 6000rpm is centrifuged 10min, and obtained precipitating is steamed with double
After water washing 4 times, nitrogen drying is dry, and 4 DEG C are sealed；
(2)N-CDs-SiO2The preparation of fluorescence probe
By the SiO of 2mg surface carboxylation2Nano particle and 2mg N, N'- carbonyl dimidazoles are added to 400 μ L N, N- bis-
In methylformamide, magnetic agitation reacts 3h at room temperature；Add it to 1mL concentration be l mg/mL N-CDs solution in,
15min is added, room temperature is protected from light be stirred to react 4h after；20 μ L ethyl orthosilicates, 0.12g monoxone, 0.25mg N- are added again
CDs particle, room temperature, which is protected from light, is stirred to react 2h progress involucrum, and involucrum 3 times repeatedly, nitrogen drying is dry, and 4 DEG C are sealed；
(3) label of FB1-mAb
The fluorescence probe 15mg for taking step (2) to prepare be dissolved in 1.5mL dioxane, 1.5mL DMF, 60 μ L triethylamines it is mixed
It closes in solution, ice bath 30min, 20 μ L isobutyl chlorocarbonates are added in stirring, and ice bath 2h obtains label solution；Label solution is dripped
It is added in the monoclonal antibody solution that 500 μ L concentration are l mg/mL, reaction is stirred at room temperature overnight；Under the conditions of 4 DEG C, reactant is used
The PBS buffer solution dialysis 3d of 0.01mol/L, pH 7.4, obtains the FB1-mAb solution of N-CDs label, 4 DEG C of preservations.
It is carbon source, Mercaptamine for passivator that carbon nanomaterial, which is using citric acid, is prepared by hydrothermal synthesis method
At: 1.5g citric acid and 1.62g Mercaptamine are dissolved in 7.5mL ultrapure water, shift solution after completely dissolution to 50mL
Among polytetrafluoroethylliner liner, then liner being placed in autoclave, 200 DEG C of reaction 3h after reaction filter product,
Ethanol washing 2 times, 65 DEG C of oven dryings obtain carbon nanomaterial TPCA.
Carbon nanomaterial label anti-FB1 monoclonal antibody the preparation method comprises the following steps:
(1) surface siliconization of carbon nanomaterial TPCA
Carbon nanomaterial TPCA is dispersed in the ethanol solution that volumetric concentration is 10%, being configured to concentration is 1mg/mL's
TPCA solution；2mL ammonium hydroxide is added dropwise in 2mL TPCA solution under stirring, 150rpm react at room temperature 25min, then plus
Enter 80 μ L ethyl orthosilicates, room temperature is protected from light 3h；6000rpm is centrifuged 10min after reaction, and after ethanol washing 4 times, nitrogen is blown
Dry, 4 DEG C are sealed；
(2) surface carboxylation of carbon nanomaterial TPCA
0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution A；Take 200mg table
The TPCA of face silication is added in the ethyl alcohol that volume is 2.5mL, forms solution B；Solution B is added in solution A, room temperature is stirred
Mix reaction 70min；After reaction, 6000rpm is centrifuged 10min, after obtained precipitating is washed 4 times with distilled water, nitrogen drying
Dry, 4 DEG C are sealed；
(3) label of FB1-mAb
TPCA and 2mg N, the N'- carbonyl dimidazoles of 2mg surface carboxylation are added to 400 μ L N, N- dimethyl formyls
In amine, magnetic agitation reacts 3h at room temperature, obtains label solution；Label solution is added drop-wise to the Dan Ke that 1mL concentration is l mg/mL
In grand antibody-solutions, 15min is added, 4 DEG C be protected from light be stirred to react overnight；With the 3d that dialyses under the conditions of 4 DEG C of PBS, TPCA label is obtained
FB1-mAb solution, 4 DEG C preservation.
Carbon nanomaterial is, by water and phosphorus pentoxide exothermic heat of reaction, to promote tryptophan carbonization using tryptophan as carbon source
And molecule aggregation is prepared: weighing 0.3g tryptophan and is dissolved in 500-1000 μ L ultrapure water；Until completely dissolved, it imports rapidly
In vial equipped with 3.0g phosphorus pentoxide；Restore after reactive material heat release to room temperature, distilled water be added and washs 2 times,
Centrifuging and taking supernatant, 65 DEG C of oven dryings, obtains carbon nanomaterial.
Carbon nanomaterial label anti-FB1 monoclonal antibody the preparation method comprises the following steps:
(1) surface siliconization of carbon nanomaterial
Carbon nanomaterial is dispersed in the ethanol solution that volumetric concentration is 10%, is configured to the carbon that concentration is 1mg/mL and receives
Rice solution；2mL ammonium hydroxide is added dropwise in 2mL carbon nano-solution under stirring, 150rpm react at room temperature 25min, then plus
Enter 80 μ L ethyl orthosilicates, room temperature is protected from light 3h；6000rpm is centrifuged 10min after reaction, and after ethanol washing 4 times, nitrogen is blown
Dry, 4 DEG C are sealed；
(2) surface carboxylation of carbon nanomaterial
0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution A；Take 200mg table
The carbon nanomaterial of face silication is added in the ethyl alcohol that volume is 2.5mL, forms solution B；Solution B is added in solution A,
Reaction 70min is stirred at room temperature；After reaction, 6000rpm is centrifuged 10min, after obtained precipitating is washed 4 times with distilled water,
Nitrogen drying is dry, and 4 DEG C are sealed；
(3) label of FB1-mAb
The carbon nanomaterial for weighing 12.78mg surface carboxylation is dissolved in 500 μ L n,N-Dimethylformamide, is added
9.34mg DCC sufficiently dissolves；The DMF solution that 200 μ L are dissolved with 4.17mg n-hydroxysuccinimide is added dropwise again, room temperature is stirred
Reaction 8h is mixed, label solution is obtained；Label solution is added drop-wise in the monoclonal antibody solution that 500 μ L concentration are l mg/mL, is stirred
Mix reaction overnight；With the PBS buffering dialysis 3d of 0.01mol/L, pH 7.4, carbon quantum dot fluorescent nano particle label is obtained
FB1-mAb solution, 4 DEG C of preservations.
Carbon quantum dot fluorescent nano particle is to be prepared using citric acid and methylamine salt as raw material by microwave assisting method:
0.5g citric acid and 0.176g methylamine hydrochloride are weighed, is dissolved in 5mL water, ultrasound sufficiently dissolution after mixing, is placed in function
Rate is in the micro-wave oven of 700W, and after microwave 5min, reaction terminates, natural cooling, and distilled water washs 2 times, and 65 DEG C of oven dryings obtain
To black solid, as carbon quantum dot fluorescent nano particle.
Carbon quantum dot fluorescent nano particle label anti-FB1 monoclonal antibody the preparation method comprises the following steps:
(1) surface carboxylation SiO2The preparation of nano particle
SiO is synthesized using reverse microemulsion method2Nano particle: by volume 10:30:10:1 ratio take Ttiton X-100,
Hexamethylene, n-hexyl alcohol, ultrapure water stir to form microemulsion 5.1mL, after 200 μ L ammonium hydroxide of addition stir evenly, add the 80 positive silicic acid of μ L
Ethyl ester, room temperature are protected from light for 24 hours；6000rpm is centrifuged 10min after reaction, is redissolved after ethanol washing 4 times with 1mL ethyl alcohol, shape
At solution A；0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution B；By solution A plus
Enter into solution B, reaction 70min is stirred at room temperature；After reaction, 6000rpm is centrifuged 10min, and obtained precipitating is steamed with double
After water washing 4 times, nitrogen drying is dry, and 4 DEG C are sealed；
(2) preparation of fluorescence probe
By the SiO of 2mg surface carboxylation2Nano particle and 2mg N, N'- carbonyl dimidazoles are added to 400 μ L N, N- bis-
In methylformamide, magnetic agitation reacts 3h at room temperature；Adding it to 1mL concentration is l mg/mL carbon quantum dot fluorescence nano
In particle solution, 15min is added, room temperature is protected from light be stirred to react 4h after；It is added 20 μ L ethyl orthosilicates again, 0.12g monoxone,
0.25mg carbon quantum dot fluorescent nano particle, room temperature, which is protected from light, is stirred to react 2h progress involucrum, and involucrum 3 times repeatedly, nitrogen drying is dry, and 4
It DEG C is sealed；
(3) label of FB1-mAb
The fluorescence probe for weighing 12.78mg step (2) preparation is dissolved in 500 μ L n,N-Dimethylformamide, is added
9.34mg DCC sufficiently dissolves；The DMF solution that 200 μ L are dissolved with 4.17mg n-hydroxysuccinimide is added dropwise again, room temperature is stirred
Reaction 8h is mixed, label solution is obtained；Label solution is added drop-wise in the monoclonal antibody solution that 500 μ L concentration are l mg/mL, is stirred
Mix reaction overnight；With the PBS buffering dialysis 3d of 0.01mol/L, pH 7.4, carbon quantum dot fluorescent nano particle label is obtained
FB1-mAb solution, 4 DEG C of preservations.
Test strips of the invention have that high specificity, high sensitivity, stability are high, safety is good, easy, quick, result
Show feature that is vivid, intuitive, applied widely, easy to carry and can quantifying.The needs of different levels personnel are able to satisfy, including
Professional chemical examination, customs quarantine control, health quarantine, quality-monitoring, livestock products processing, raiser and consumer individual etc..The present invention
It is extremely important in terms of ensuring food safety, protecting consumer health, will have apparent economic benefit and society
It can benefit.
Detailed description of the invention
Fig. 1 is the main view of test paper of the invention, in figure, 1 is sample pad, 2 is bonding pad, 3 is chromatographic film, 4 is absorption
Pad, 7 be bottom, 8 be surface layer.
Fig. 2 is the top view of test paper of the invention, in figure, 4 be absorption pad, 5 be it is stealthy detect trace, 6 be stealthy control
Trace, 8 are surface layer.
Specific embodiment
Specific embodiments of the present invention will be described in further detail with reference to embodiments.
Embodiment 1
The immune chromatography test paper of detection FB1 of the invention including supporter and is fixed on supporter referring to Fig.1-2
Adsorption layer, adsorption layer are followed successively by sample pad 1, bonding pad 2, chromatographic film 3 and absorption pad 4, the bonding pad since test lead
On be adsorbed with nano material label anti-FB1 monoclonal antibody FB1-mAb；The chromatographic film is equipped with the load with coupling FB1
The stealthy detection trace 5 of body protein (FB1 artificial antigen) solution printing and with goat-anti or the printing of rabbit anti-mouse IgG antibody solution
Stealth control trace 6；The nano material is nitrogen-doped carbon nano material, carbon nanomaterial, carbon quantum dot fluorescence nano
Grain.
The supporter includes the bottom 7 that adsorption layer bottom surface is arranged in and the surface layer 8 that adsorption layer top surface is arranged in.
The supporting plate material is the toughness PVC material not absorbed water.
The sample cushion material can also be nylon membrane, PVDF membrane or polyester film in addition to glass fibre cotton.
The combination cushion material is glass fibre cotton.
The chromatography membrane material can also be pure cellulose film or carboxylated cellulose film in addition to nitrocellulose filter.
The water suction cushion material is strong water absorption function filter paper.
The carrier protein of the described coupling FB1 except bovine serum albumin(BSA) (BSA) in addition to, can also be chicken egg white (OVA) or
Hemocyanin (KLH).
The described stealthy detection trace and stealthy control trace are Chu " ∣ ∣ " it can also be " 10 " font in addition to linear trace
Arrange trace, " ┬ ┬ " font arrangement trace, " ┴ ┴ " font arrangement trace, " ├ ├ " font arrangement trace or " ┤ ┤ " font
Arrange trace.
It is printed with red samples label warning line in sample pad surface layer corresponding with bonding pad intersection, and is printed on max
Printed words, the label alert at the side 1.1-1.2cm of linear distance sample pad top.
It is white that the surface layer, which is covered on above sample pad and bonding pad, and being covered on is blue above water absorption pad,
It can be also other colors (such as green).
Embodiment 2
The present embodiment detects FB1 test paper, specifically includes that preparation, the FB1 monoclonal antibody (FB1- of FB1 artificial antigen
MAb), the preparation of nitrogen-doped carbon nano material (N-CDs) flag F B1 antibody and the immune chromatography test paper based on N-CDs label
Preparation, wherein each product the preparation method is as follows:
1, the preparation of FB1 artificial antigen (FB1-BSA)
Using EDC method, FB1 and carrier protein BSA are coupled, prepare artificial antigen.
The bovine serum albumin(BSA) (BSA) for weighing 10mg is placed in 10mL screw socket bottle, with the NaHCO of 0.13mol/L3Solution system
At mass fraction 10%BSA activated solution, adjusting pH is 7.6.1mg FB1,1.073mg N are weighed, N- dicyclohexyl phosphinylidyne is sub-
Amine (DCC) and 0.598mg n-hydroxysuccinimide (NHS), are dissolved in anhydrous tetrahydro furan, 30 DEG C of oscillation 4h, then
4000r/min is centrifuged 15min, abandons supernatant, and wash precipitating with anhydrous tetrahydro furan, it is to be precipitated in tetrahydrofuran volatilize completely
Afterwards, 0.2mL n,N-Dimethylformamide is dissolved the residue in.And this solution is slowly dropped in BSA activated solution, it is placed in
On magnetic stirring apparatus, it is protected from light room temperature reaction overnight.Reaction product is dialysed 3d under 4 DEG C of stirrings with PBS, changes liquid 3-6 times daily, thoroughly
The FB1-BSA purified after analysis.
2, the preparation of FB1-mAb
Animal immune: the dosage with the artificial antigen FB1-BSA of preparation with 20-25 μ g/ only, it is immune using 4 points of back
Method is immunized 6-8 week old Balb/C female rat 4 times, and head exempts to be emulsified with Freund's complete adjuvant, remaining is emulsified with incomplete Freund's adjuvant,
Each 3 weeks immunization interval time selects the mouse that antibody titer is high, inhibiting rate is good for 4 weeks after last time is immune, carries out superpower exempt from
Epidemic disease.
Cell fusion: it is superpower immune 3 days latter, sinus under immune mouse socket of the eye is taken into blood, neck is taken off and puts to death, take spleen；With 75%
Alcohol impregnates mouse 5-10min and sterilizes body surface, sterile to take its spleen, and spleen is shredded and ground, through 120 mesh nylon gauze mistakes
Filter, 1000rpm are centrifuged 10min, collect splenocyte.By splenocyte and NS0Myeloma cell is in the ratio of 10:1 in centrifuge tube
Mixing, places it in 40 DEG C of water-baths；1mL PEG-1500 is added in centrifuge tube in 60s along tube wall, is continued in water-bath light
After shaking reaction 90s, according to 1mL/30s, centrifuge tube is added in 37 DEG C of 15mL of GNK solution by the speed of 3mL/30s, 11mL/30s
In, 5min is then reacted in 37 DEG C of water-baths, 1000rpm is centrifuged 10min, abandons supernatant；After breaing up cell mass, 40mL is added
HAT culture medium is added on feeder cells culture plate after mixing, and 100 holes μ L/ set 37 DEG C, 5%CO2In incubator.
The screening of monoclonal antibody: culture 10-14 days carries out positive hole with indirect elisa method and screens, selection strong positive,
Inhibiting rate is high, (until cell clone is monoclonal, detection is each for 3-6 limited dilution cloning of cell eugonic hole progress
A clone hole potency inhibits valence almost the same), then expand culture, establishes hybridoma cell strain.Prepared hybridoma
The monoclonal antibody of secretion can specifically be reacted with FB1, and affinity constant reaches 1010-1012L/mol, light chain subtype are κ or λ,
Heavy chain subgroup is IgG1、IgG2a、IgG2b、IgG3。
3, the preparation of the immune chromatography test paper based on N-CDs label
(1) nitrogen-doped carbon nano material N-CDs is prepared using hydro-thermal method
Chitosan 2.5g is dissolved in 5mL ultrapure water, 5mL ethylenediamine is added, mixing is placed on poly- the four of autoclave
In vinyl fluoride liner, 180 DEG C of reaction 2h after reaction filter product, and distilled water washs 2 times, and 60 DEG C of oven dryings obtain
N-CDs。
(2) surface carboxylation SiO2The preparation of nano particle
SiO is synthesized using reverse microemulsion method2Nano particle: by volume 10:30:10:1 ratio take Ttiton X-100,
Hexamethylene, n-hexyl alcohol, ultrapure water stir to form microemulsion 5.1mL, after 200 μ L ammonium hydroxide of addition stir evenly, add the 80 positive silicic acid of μ L
Ethyl ester, room temperature are protected from light for 24 hours；6000rpm is centrifuged 10min after reaction, is redissolved after ethanol washing 4 times with 1mL ethyl alcohol, shape
At solution A；0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution B；By solution A plus
Enter into solution B, reaction 70min is stirred at room temperature；After reaction, 6000rpm is centrifuged 10min, and obtained precipitating is steamed with double
After water washing 4 times, nitrogen drying is dry, and 4 DEG C are sealed.
(3)N-CDs-SiO2The preparation of fluorescence probe
By the SiO of 2mg surface carboxylation2Nano particle and 2mg N, N'- carbonyl dimidazoles are added to 400 μ LN, N- diformazans
In base formamide, magnetic agitation reacts 3h at room temperature；Adding it to 1mL concentration is l mg/mLN-CDs solution (0.1mol/
LNaOH solution dissolution) in, 15min is added, room temperature is protected from light be stirred to react 4h after；20 μ L ethyl orthosilicates, 0.12g are added again
Monoxone, 0.25mg N-CDs particle, room temperature, which is protected from light, is stirred to react 2h progress involucrum, and involucrum 3 times repeatedly, nitrogen drying is dry, and 4 DEG C close
Envelope saves；
(4) label of FB1-mAb
The fluorescence probe 15mg for taking step (2) to prepare is dissolved in 1.5mL dioxane, 1.5mL DMF (N, N- dimethyl formyl
Amine), in the mixed solutions of 60 μ L triethylamines, 20 μ L isobutyl chlorocarbonates are added in ice bath 30min, stirring, and ice bath 2h is marked
Solution；Label solution is added drop-wise in the monoclonal antibody solution that 500 μ L concentration are l mg/mL, reaction is stirred at room temperature overnight；4
Under the conditions of DEG C, the PBS buffer solution dialysis 3d of reactant 0.01mol/L, pH 7.4 obtains the FB1-mAb of N-CDs label
(N-CDs-FB1-mAb) solution, 4 DEG C of preservations.
(5) preparation of the immune chromatography test paper based on N-CDs label
By N-CDs-FB1-mAb solution spraying on glass fibre membrane, 37 DEG C of freeze-day with constant temperature 4h form bonding pad；By FB1
Artificial antigen is drawn in chromatographic film respectively together with goat-anti or rabbit-anti IgG solution, and form two markings: one is stealthy detection print
Mark (T line), one be stealthy control trace (C line), 37 DEG C of freeze-day with constant temperature are stayed overnight, and chromatographic film is made；By sample pad, bonding pad,
After chromatographic film, absorption pad are pasted on bottom in order, then surface layer is pasted, cuts into suitable dimension and obtain test paper product.
Detect reaction principle
After test paper test lead is inserted into testing sample solution, under siphonage drive, solution to be measured can be from the survey of test paper
Examination end is diffused into handle end.
In diffusion process, the fumonisins B1 in solution to be measured can be combined with N-CDs-FB1-mAb, and then close N-
The antigen-combining site of the upper fumonisins B1 of CDs-FB1-mAb prevents the detection trace knot in N-CDs-FB1-mAb and chromatographic film
It closes, and compareing goat-anti or rabbit anti-mouse IgG antibody on trace then can read an instrument by fluorescence in conjunction with N-CDs-FB1-mAb,
Under ultraviolet light excitation, would not occur absorption peak at T line, will appear absorption peak at C line.If otherwise without volt horse bacterium in sample solution
When plain B1, then it cannot prevent N-CDs-FB1-mAb in conjunction with the detection trace in chromatographic film, and goat-anti or rabbit anti-mouse IgG are anti-
Body also can read an instrument by fluorescence in conjunction with N-CDs-FB1-mAb, under ultraviolet light excitation, will appear suction at T line and C line
Receive peak.If there is no C line absorption peak in chromatographic film, show that test strips have failed.
Sensitivity, specific detection of the present embodiment to the test paper of the quantitative detection FB1 marked based on N-CDs.
The detection of sensitivity: with PBS be respectively configured concentration be 500,250,125,62.5,31.25,15.62,0ng/mL
FB1 standard items are placed in polystyrene aperture, and test strips test lead is inserted into liquid level, about 1-2min taking-up test paper, at 25 DEG C
It is put into fluorescence reading instrument after placing 5min, an instrument is read by fluorescence and directly reads peak figure.Using peak value or peak area as ordinate, with
The logarithm of different FB1 concentration is abscissa, draws standard suppression curve, carries out correlation regression analysis, calculates the test paper to FB1
IC50And minimum detection limit.After measured, Regression Equations of the test paper to FB1 are as follows: y=-0.5395x+1.5532 is related
Coefficient is R2=0.9985, which is gone out to the IC of FB1 according to regression equation calculation50For 89.12ng/mL, lowest detection is limited to
25.12ng/mL shows immune chromatography test paper to FB1 sensitivity with higher.
Specificity detection: with fumonisins B1, T-2 toxin, zearalenone, ochratoxin A, patulin,
For ergotoxin as competitor, configuring above-mentioned mark product concentration is 2mg/mL, detects it with the immune chromatography test paper that N-CDs is marked
Inhibiting rate calculates cross reacting rate according to formula.
Measurement result see the table below 1, and the specificity of the immune chromatography test paper of the quantitative detection FB1 of N-CDs label is preferable, with
The equal no cross reaction of other toxin.
The cross reactivity of immune chromatography test paper of the table 1 based on the N-CDs quantitative detection fumonisins B1 marked
| Compound | Half-inhibitory concentration (ng/mL) | Cross reacting rate (%) |
| Fumonisins B1 | 89.12 | 100 |
| T-2 toxin | > 1.0 × 105 | <0.04 |
| Zearalenone | > 1.0 × 105 | <0.04 |
| Ochratoxin A | > 1.0 × 105 | <0.04 |
| Patulin | > 1.0 × 105 | <0.04 |
| Ergotoxin | > 1.0 × 105 | <0.04 |
Quantitative detection: test strips test lead is inserted into detection liquid, and liquid level does not exceed sample label warning line, about 1-
2min takes out test paper, is put into fluorescence reading instrument after placement 5min at 25 DEG C and directly reads quantitative detection value.
Embodiment 3
The present embodiment detects FB1 test paper, specifically includes that preparation, the FB1 monoclonal antibody (FB1- of FB1 artificial antigen
MAb), the preparation of carbon nanomaterial flag F B1 antibody and the preparation etc. of the immune chromatography test paper based on carbon nanomaterial label
Step, wherein each product the preparation method is as follows:
1, the preparation of FB1 artificial antigen (FB1-BSA)
With embodiment 2.
2, the preparation of FB1-mAb
With embodiment 2.
3, the preparation of the immune chromatography test paper based on carbon nanomaterial label
(1) preparation of carbon nanomaterial TPCA
1.5g citric acid and 1.62g Mercaptamine are dissolved in 7.5mL ultrapure water, shift solution extremely after completely dissolution
Among 50mL polytetrafluoroethylliner liner, then liner is placed in autoclave, 200 DEG C of reaction 3h, after reaction by product
It filters, ethanol washing 2 times, 65 DEG C of oven dryings obtain carbon nanomaterial TPCA.
(2) surface siliconization of carbon nanomaterial TPCA
Carbon nanomaterial TPCA is dispersed in the ethanol solution that volumetric concentration is 10%, being configured to concentration is 1mg/mL's
TPCA solution；2mL ammonium hydroxide is added dropwise in 2mL TPCA solution under stirring, 150rpm react at room temperature 25min, then plus
Enter 80 μ L ethyl orthosilicates, room temperature is protected from light 3h；6000rpm is centrifuged 10min after reaction, and after ethanol washing 4 times, nitrogen is blown
Dry, 4 DEG C are sealed
(3) surface carboxylation of carbon nanomaterial TPCA
0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution A；Take 200mg table
The TPCA of face silication is added in the ethyl alcohol that volume is 2.5mL, forms solution B；Solution B is added in solution A, room temperature is stirred
Mix reaction 70min；After reaction, 6000rpm is centrifuged 10min, after obtained precipitating is washed 4 times with distilled water, nitrogen drying
Dry, 4 DEG C are sealed.
(4) label of FB1-mAb
TPCA and 2mg N, the N'- carbonyl dimidazoles of 2mg surface carboxylation are added to 400 μ LN, dinethylformamide
In, magnetic agitation reacts 3h at room temperature, obtains label solution；Label solution is added drop-wise to the monoclonal that 1mL concentration is l mg/mL
In antibody-solutions, 15min is added, 4 DEG C be protected from light be stirred to react overnight；With the 3d that dialyses under the conditions of 4 DEG C of PBS, TPCA label is obtained
FB1-mAb solution, 4 DEG C of preservations.
Reaction principle is detected with embodiment 2.
Sensitivity, specific detection of the present embodiment to the immune chromatography test paper of the quantitative detection FB1 marked based on TPCA.
The detection of sensitivity: method is the same as embodiment 2.After measured, Regression Equations of the test paper to FB1 are as follows: y=-
0.4740x+1.4371, related coefficient R2=0.9992, which is gone out to the IC of FB1 according to regression equation calculation50For
95.50ng/mL, lowest detection are limited to 22.08ng/mL.Show immune chromatography test paper to FB1 sensitivity with higher.
The detection of specificity: method is the same as embodiment 2.Measurement result see the table below 2, the quantitative detection FB1's of TPCA label
The specificity of immune chromatography test paper is preferable, with the equal no cross reaction of other toxin.
The cross reactivity of immune chromatography test paper of the table 2 based on the TPCA quantitative detection fumonisins B1 marked
| Compound | Half-inhibitory concentration (ng/mL) | Cross reacting rate (%) |
| Fumonisins B1 | 95.50 | 100 |
| T-2 toxin | > 1.0 × 105 | <0.04 |
| Zearalenone | > 1.0 × 105 | <0.04 |
| Ochratoxin A | > 1.0 × 105 | <0.04 |
| Patulin | > 1.0 × 105 | <0.04 |
| Ergotoxin | > 1.0 × 105 | <0.04 |
Quantitative detection: method is the same as embodiment 2.
Embodiment 4
The present embodiment detects FB1 test paper, specifically includes that preparation, the FB1 monoclonal antibody (FB1- of FB1 artificial antigen
MAb), the preparation of carbon nanomaterial flag F B1 antibody and the preparation etc. of the immune chromatography test paper based on carbon nanomaterial label
Step, wherein each product the preparation method is as follows:
1, the preparation of FB1 artificial antigen (FB1-BSA)
With embodiment 2.
2, the preparation of FB1-mAb
With embodiment 2.
3, the preparation of the immune chromatography test paper based on carbon nanomaterial label
(1) preparation of carbon nanomaterial
0.3g tryptophan is weighed to be dissolved in 500-1000 μ L ultrapure water；Until completely dissolved, it imports rapidly and 3.0g five is housed
In the vial for aoxidizing two phosphorus；Restore after reactive material heat release to room temperature, appropriate distilled water is added and washs 2 times, centrifuging and taking
Supernatant, 65 DEG C of oven dryings, obtains carbon nanomaterial.
(2) surface siliconization of carbon nanomaterial
Carbon nanomaterial is dispersed in the ethanol solution that volumetric concentration is 10%, is configured to the carbon that concentration is 1mg/mL and receives
Rice solution；2mL ammonium hydroxide is added dropwise in 2mL carbon nano-solution under stirring, 150rpm react at room temperature 25min, then plus
Enter 80 μ L ethyl orthosilicates, room temperature is protected from light 3h；6000rpm is centrifuged 10min after reaction, and after ethanol washing 4 times, nitrogen is blown
Dry, 4 DEG C are sealed；
(3) surface carboxylation of carbon nanomaterial
0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution A；Take 200mg table
The carbon nanomaterial of face silication is added in the ethyl alcohol that volume is 2.5mL, forms solution B；Solution B is added in solution A,
Reaction 70min is stirred at room temperature；After reaction, 6000rpm is centrifuged 10min, after obtained precipitating is washed 4 times with distilled water,
Nitrogen drying is dry, and 4 DEG C are sealed；
(4) label of FB1-mAb
The carbon nanomaterial for weighing 12.78mg surface carboxylation is dissolved in 500 μ L n,N-Dimethylformamide, is added
9.34mg DCC sufficiently dissolves；The DMF solution that 200 μ L are dissolved with 4.17mg n-hydroxysuccinimide is added dropwise again, room temperature is stirred
Reaction 8h is mixed, label solution is obtained；Label solution is added drop-wise in the monoclonal antibody solution that 500 μ L concentration are l mg/mL, is stirred
Mix reaction overnight；With the PBS buffering dialysis 3d of 0.01mol/L, pH 7.4, carbon quantum dot fluorescent nano particle label is obtained
FB1-mAb solution, 4 DEG C of preservations.
Reaction principle is detected with embodiment 2.
The present embodiment is to the sensitivity of the immune chromatography test paper of the quantitative detection FB1 marked based on carbon nanomaterial, special
Property detection.
The detection of sensitivity: method is the same as embodiment 2.After measured, Regression Equations of the test paper to FB1 are as follows: y=-
0.4504x+1.3439, related coefficient R2=0.9988, which is gone out to the IC of FB1 according to regression equation calculation50For
74.13ng/mL, lowest detection are limited to 16.11ng/mL.Show immune chromatography test paper to FB1 sensitivity with higher.
The detection of specificity: method is the same as embodiment 2.Measurement result see the table below 3, the quantitative detection of carbon nanomaterial label
The specificity of the immune chromatography test paper of FB1 is preferable, with the equal no cross reaction of other toxin.
The cross reactivity of the immune chromatography test paper for the quantitative detection fumonisins B1 that table 3 is marked based on carbon nanomaterial
| Compound | Half-inhibitory concentration (ng/mL) | Cross reacting rate (%) |
| Fumonisins B1 | 74.13 | 100 |
| T-2 toxin | > 1.0 × 105 | <0.04 |
| Zearalenone | > 1.0 × 105 | <0.04 |
| Ochratoxin A | > 1.0 × 105 | <0.04 |
| Patulin | > 1.0 × 105 | <0.04 |
| Ergotoxin | > 1.0 × 105 | <0.04 |
Quantitative detection: method is the same as embodiment 2.
Embodiment 5
The present embodiment detects FB1 test paper, specifically includes that preparation, the FB1 monoclonal antibody (FB1- of FB1 artificial antigen
MAb), the preparation of carbon quantum dot fluorescent nano particle flag F B1 antibody and based on carbon quantum dot fluorescent nano particle label
The preparation of immune chromatography test paper, wherein each product the preparation method is as follows:
1, the preparation of FB1 artificial antigen (FB1-BSA)
With embodiment 2.
2, the preparation of FB1-mAb
With embodiment 2.
3, the preparation of the immune chromatography test paper based on carbon quantum dot fluorescent nano particle label
(1) preparation of carbon quantum dot fluorescent nano particle
0.5g citric acid and 0.176g methylamine hydrochloride are weighed, is dissolved in 5mL water, ultrasound sufficiently dissolves after mixing,
It is placed in the micro-wave oven that power is 700W, after microwave 5min, reaction terminates, natural cooling, and distilled water washs 2 times, 65 DEG C of bakings
Case is dry, obtains black solid, as carbon quantum dot fluorescent nano particle.
(2) surface carboxylation SiO2The preparation of nano particle
SiO is synthesized using reverse microemulsion method2Nano particle: by volume 10:30:10:1 ratio take Ttiton X-100,
Hexamethylene, n-hexyl alcohol, ultrapure water stir to form microemulsion 5.1mL, after 200 μ L ammonium hydroxide of addition stir evenly, add the 80 positive silicic acid of μ L
Ethyl ester, room temperature are protected from light for 24 hours；6000rpm is centrifuged 10min after reaction, is redissolved after ethanol washing 4 times with 1mL ethyl alcohol, shape
At solution A；0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution B；By solution A plus
Enter into solution B, reaction 70min is stirred at room temperature；After reaction, 6000rpm is centrifuged 10min, and obtained precipitating is steamed with double
After water washing 4 times, nitrogen drying is dry, and 4 DEG C are sealed；
(3) preparation of fluorescence probe
By the SiO of 2mg surface carboxylation2Nano particle and 2mg N, N'- carbonyl dimidazoles are added to 400 μ L N, N- bis-
In methylformamide, magnetic agitation reacts 3h at room temperature；Adding it to 1mL concentration is l mg/mL carbon quantum dot fluorescence nano
In particle solution (dissolution of 0.1mol/L NaOH solution), 15min is added, room temperature is protected from light be stirred to react 4h after；20 μ L are added again
Ethyl orthosilicate, 0.12g monoxone, 0.25mg carbon quantum dot fluorescent nano particle, room temperature, which is protected from light, is stirred to react 2h progress involucrum,
Involucrum 3 times repeatedly, nitrogen drying is dry, and 4 DEG C are sealed；
(3) label of FB1-mAb
The fluorescence probe for weighing 12.78mg step (2) preparation is dissolved in 500 μ L n,N-Dimethylformamide, is added
9.34mg DCC sufficiently dissolves；The DMF solution that 200 μ L are dissolved with 4.17mg n-hydroxysuccinimide is added dropwise again, room temperature is stirred
Reaction 8h is mixed, label solution is obtained；Label solution is added drop-wise in the monoclonal antibody solution that 500 μ L concentration are l mg/mL, is stirred
Mix reaction overnight；With the PBS buffering dialysis 3d of 0.01mol/L, pH 7.4, carbon quantum dot fluorescent nano particle label is obtained
FB1-mAb solution, 4 DEG C of preservations.
Reaction principle is detected with embodiment 2.
The immune chromatography test paper for the quantitative detection FB1 that the present embodiment marks base carbon quantum dot fluorescent nano particle it is sensitive
Property, specific detection.
The detection of sensitivity: method is the same as embodiment 2.After measured, Regression Equations of the test paper to FB1 are as follows: y=-
0.5394x+1.5310, related coefficient R2=0.9966, which is gone out to the IC of FB1 according to regression equation calculation50For
81.28ng/mL, lowest detection are limited to 22.65ng/mL.Show immune chromatography test paper to FB1 sensitivity with higher.
The detection of specificity: method is the same as embodiment 2.Measurement result see the table below 4, carbon quantum dot fluorescent nano particle label
Quantitative detection FB1 immune chromatography test paper specificity preferably, with the equal no cross reaction of other toxin.
The friendship of the immune chromatography test paper for the quantitative detection fumonisins B1 that table 4 is marked based on carbon quantum dot fluorescent nano particle
Fork reactivity
| Compound | Half-inhibitory concentration (ng/mL) | Cross reacting rate (%) |
| Fumonisins B1 | 81.28 | 100 |
| T-2 toxin | > 1.0 × 105 | <0.04 |
| Zearalenone | > 1.0 × 105 | <0.04 |
| Ochratoxin A | > 1.0 × 105 | <0.04 |
| Patulin | > 1.0 × 105 | <0.04 |
| Ergotoxin | > 1.0 × 105 | <0.04 |
Quantitative detection: method is the same as embodiment 2.
The foregoing is merely the optimal embodiments of the present invention, and for those skilled in the art, the present invention can have
Various modifications and variations.All within the spirits and principles of the present invention, any modification, equivalent replacement, improvement and so on, should all
It is included within protection scope of the present invention.
Claims (10)
1. a kind of immune chromatography test paper for detecting fumonisins B1 is inhaled including supporter and the adsorption layer being fixed on supporter
Attached layer is followed successively by sample pad (1), bonding pad (2), chromatographic film (3) and absorption pad (4) since test lead, which is characterized in that institute
The anti-FB1 monoclonal antibody of nano material label is adsorbed on the bonding pad stated；The chromatographic film is equipped with manually to be resisted with FB1
Stealthy detection trace (5) of original solution printing and the stealthy control trace printed with goat-anti or rabbit anti-mouse IgG antibody solution
(6)；The nano material is nitrogen-doped carbon nano material, carbon nanomaterial, carbon quantum dot fluorescent nano particle.
2. the immune chromatography test paper of detection fumonisins B1 according to claim 1, which is characterized in that the supporter
Including the bottom (7) that adsorption layer bottom surface is arranged in and the surface layer (8) that adsorption layer top surface is arranged in.
3. the immune chromatography test paper of detection fumonisins B1 according to claim 1, which is characterized in that the N doping
Carbon nanomaterial N-CDs is using chitosan as carbon source, and ethylenediamine is nitrogen dopant, is prepared using hydro-thermal method, specific method
Are as follows: chitosan 2.5g is dissolved in 5mL ultrapure water, 5mL ethylenediamine is added, mixes the polytetrafluoroethylene (PTFE) for being placed on autoclave
In liner, 180 DEG C of reaction 2h after reaction filter product, and distilled water washs 2 times, and 60 DEG C of oven dryings obtain N-CDs.
4. the immune chromatography test paper of detection fumonisins B1 according to claim 1-3, which is characterized in that described
Nitrogen-doped carbon nano material label anti-FB1 monoclonal antibody the preparation method comprises the following steps:
(1) surface carboxylation SiO2The preparation of nano particle
SiO is synthesized using reverse microemulsion method2Nano particle: 10:30:10:1 ratio takes Ttiton X-100, hexamethylene by volume
Alkane, n-hexyl alcohol, ultrapure water stir to form 5.1mL microemulsion, after 200 μ L ammonium hydroxide of addition stir evenly, add 80 μ L ethyl orthosilicates,
Room temperature is protected from light for 24 hours；6000rpm is centrifuged 10min after reaction, is redissolved, is formed molten with 1mL ethyl alcohol after ethanol washing 4 times
Liquid A；0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution B；Solution A is added to
In solution B, reaction 70min is stirred at room temperature；After reaction, 6000rpm is centrifuged 10min, and obtained precipitating is washed with distilled water
After washing 4 times, nitrogen drying is dry, and 4 DEG C are sealed；
(2)N-CDs-SiO2The preparation of fluorescence probe
By the SiO of 2mg surface carboxylation2Nano particle and 2mg N, N'- carbonyl dimidazoles are added to 400 μ L N, N- dimethyl methyls
In amide, magnetic agitation reacts 3h at room temperature；Adding it to 1mL concentration is in l mg/mL N-CDs solution, and 15min is added,
Room temperature is protected from light be stirred to react 4h after；20 μ L ethyl orthosilicates, 0.12g monoxone, 0.25mg N-CDs particle, room temperature are added again
It is protected from light and is stirred to react 2h progress involucrum, involucrum 3 times repeatedly, nitrogen drying is dry, and 4 DEG C are sealed；
(3) label of FB1-mAb
It is molten that the fluorescence probe 15mg for taking step (2) to prepare is dissolved in 1.5mL dioxane, 1.5mL DMF, the mixing of 60 μ L triethylamines
In liquid, 20 μ L isobutyl chlorocarbonates are added in ice bath 30min, stirring, and ice bath 2h obtains label solution；Label solution is added drop-wise to
500 μ L concentration are that reaction is stirred at room temperature overnight in the monoclonal antibody solution of l mg/mL；Under the conditions of 4 DEG C, reactant is used
The PBS buffer solution dialysis 3d of 0.01mol/L, pH 7.4, obtains the FB1-mAb solution of N-CDs label, 4 DEG C of preservations.
5. the immune chromatography test paper of detection fumonisins B1 according to claim 1, which is characterized in that the carbon nanometer
It is carbon source, Mercaptamine for passivator that material, which is using citric acid, is prepared by hydrothermal synthesis method: by 1.5g citric acid
Be dissolved in 7.5mL ultrapure water with 1.62g Mercaptamine, after completely dissolution shift solution to 50mL polytetrafluoroethylliner liner it
In, then liner is placed in autoclave, 200 DEG C of reaction 3h after reaction filter product, ethanol washing 2 times, 65 DEG C
Oven drying obtains carbon nanomaterial TPCA.
6. according to claim 1, detecting the immune chromatography test paper of fumonisins B1 described in 2 or 5, which is characterized in that described
Carbon nanomaterial label anti-FB1 monoclonal antibody the preparation method comprises the following steps:
(1) surface siliconization of carbon nanomaterial TPCA
Carbon nanomaterial TPCA is dispersed in the ethanol solution that volumetric concentration is 10%, is configured to the TPCA that concentration is 1mg/mL
Solution；2mL ammonium hydroxide is added dropwise in 2mL TPCA solution under stirring, 150rpm reacts at room temperature 25min, is then added 80
μ L ethyl orthosilicate, room temperature are protected from light 3h；6000rpm is centrifuged 10min after reaction, after ethanol washing 4 times, nitrogen drying
Dry, 4 DEG C are sealed；
(2) surface carboxylation of carbon nanomaterial TPCA
0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution A；Take 200mg surface silicon
The TPCA of change is added in the ethyl alcohol that volume is 2.5mL, forms solution B；Solution B is added in solution A, is stirred at room temperature anti-
Answer 70min；After reaction, 6000rpm is centrifuged 10min, and after obtained precipitating is washed 4 times with distilled water, nitrogen drying is dry, and 4
It DEG C is sealed；
(3) label of FB1-mAb
TPCA and 2mg N, the N'- carbonyl dimidazoles of 2mg surface carboxylation are added in 400 μ L n,N-Dimethylformamide,
Magnetic agitation reacts 3h at room temperature, obtains label solution；Label solution is added drop-wise to the monoclonal that 1mL concentration is l mg/mL to resist
In liquid solution, 15min is added, 4 DEG C be protected from light be stirred to react overnight；With the 3d that dialyses under the conditions of 4 DEG C of PBS, TPCA label is obtained
FB1-mAb solution, 4 DEG C of preservations.
7. the immune chromatography test paper of detection fumonisins B1 according to claim 1, which is characterized in that the carbon nanometer
Material is, by water and phosphorus pentoxide exothermic heat of reaction, to promote tryptophan carbonization and molecule aggregation preparation using tryptophan as carbon source
It forms: weighing 0.3g tryptophan and be dissolved in 500-1000 μ L ultrapure water；Until completely dissolved, it imports rapidly and is aoxidized equipped with 3.0g five
In the vial of two phosphorus；Restore after reactive material heat release to room temperature, distilled water is added and washs 2 times, centrifuging and taking supernatant, 65 DEG C
Oven drying obtains carbon nanomaterial.
8. according to claim 1, detecting the immune chromatography test paper of fumonisins B1 described in 2 or 7, which is characterized in that described
Carbon nanomaterial label anti-FB1 monoclonal antibody the preparation method comprises the following steps:
(1) surface siliconization of carbon nanomaterial
Carbon nanomaterial is dispersed in the ethanol solution that volumetric concentration is 10%, it is molten to be configured to the carbon nanometer that concentration is 1mg/mL
Liquid；2mL ammonium hydroxide is added dropwise in 2mL carbon nano-solution under stirring, 150rpm reacts at room temperature 25min, and 80 μ are then added
L ethyl orthosilicate, room temperature are protected from light 3h；6000rpm is centrifuged 10min after reaction, and after ethanol washing 4 times, nitrogen drying is dry,
4 DEG C are sealed；
(2) surface carboxylation of carbon nanomaterial
0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution A；Take 200mg surface silicon
The carbon nanomaterial of change is added in the ethyl alcohol that volume is 2.5mL, forms solution B；Solution B is added in solution A, room temperature
It is stirred to react 70min；After reaction, 6000rpm is centrifuged 10min, and after obtained precipitating is washed 4 times with distilled water, nitrogen is blown
Dry, 4 DEG C are sealed；
(3) label of FB1-mAb
The carbon nanomaterial for weighing 12.78mg surface carboxylation is dissolved in 500 μ L n,N-Dimethylformamide, is added
9.34mg DCC sufficiently dissolves；The DMF solution that 200 μ L are dissolved with 4.17mg n-hydroxysuccinimide is added dropwise again, room temperature is stirred
Reaction 8h is mixed, label solution is obtained；Label solution is added drop-wise in the monoclonal antibody solution that 500 μ L concentration are l mg/mL, is stirred
Mix reaction overnight；With the PBS buffering dialysis 3d of 0.01mol/L, pH 7.4, carbon quantum dot fluorescent nano particle label is obtained
FB1-mAb solution, 4 DEG C of preservations.
9. the immune chromatography test paper of detection fumonisins B1 according to claim 1, which is characterized in that the carbon quantum
Point fluorescent nano particle is to be prepared using citric acid and methylamine salt as raw material by microwave assisting method: weighing 0.5g citric acid
It with 0.176g methylamine hydrochloride, is dissolved in 5mL water, ultrasound sufficiently dissolution after mixing, is placed in the microwave that power is 700W
In furnace, after microwave 5min, reaction terminates, natural cooling, and distilled water washs 2 times, and 65 DEG C of oven dryings obtain black solid, i.e.,
For carbon quantum dot fluorescent nano particle.
10. according to claim 1, detecting the immune chromatography test paper of fumonisins B1 described in 2 or 9, which is characterized in that described
Carbon quantum dot fluorescent nano particle label anti-FB1 monoclonal antibody the preparation method comprises the following steps:
(1) surface carboxylation SiO2The preparation of nano particle
SiO is synthesized using reverse microemulsion method2Nano particle: 10:30:10:1 ratio takes Ttiton X-100, hexamethylene by volume
Alkane, n-hexyl alcohol, ultrapure water stir to form microemulsion 5.1mL, after 200 μ L ammonium hydroxide of addition stir evenly, add 80 μ L ethyl orthosilicates,
Room temperature is protected from light for 24 hours；6000rpm is centrifuged 10min after reaction, is redissolved, is formed molten with 1mL ethyl alcohol after ethanol washing 4 times
Liquid A；0.47g monoxone is added in the NaOH solution that 2.5mL concentration is 6mol/L, forms solution B；Solution A is added to
In solution B, reaction 70min is stirred at room temperature；After reaction, 6000rpm is centrifuged 10min, and obtained precipitating is washed with distilled water
After washing 4 times, nitrogen drying is dry, and 4 DEG C are sealed；
(2) preparation of fluorescence probe
By the SiO of 2mg surface carboxylation2Nano particle and 2mg N, N'- carbonyl dimidazoles are added to 400 μ LN, N- dimethyl methyls
In amide, magnetic agitation reacts 3h at room temperature；Adding it to 1mL concentration is that l mg/mL carbon quantum dot fluorescent nano particle is molten
In liquid, 15min is added, room temperature is protected from light be stirred to react 4h after；20 μ L ethyl orthosilicates, 0.12g monoxone, 0.25mg are added again
Carbon quantum dot fluorescent nano particle, room temperature, which is protected from light, is stirred to react 2h progress involucrum, and involucrum 3 times repeatedly, nitrogen drying is dry, 4 DEG C of sealings
It saves；
(3) label of FB1-mAb
The fluorescence probe for weighing 12.78mg step (2) preparation is dissolved in 500 μ L n,N-Dimethylformamide, adds 9.34mg
DCC sufficiently dissolves；The DMF solution that 200 μ L are dissolved with 4.17mg n-hydroxysuccinimide is added dropwise again, reaction is stirred at room temperature
8h obtains label solution；Label solution is added drop-wise in the monoclonal antibody solution that 500 μ L concentration are l mg/mL, is stirred to react
Overnight；With the PBS buffering dialysis 3d of 0.01mol/L, pH 7.4, the FB1-mAb of carbon quantum dot fluorescent nano particle label is obtained
Solution, 4 DEG C of preservations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810992495.9A CN109085336B (en) | 2018-08-29 | 2018-08-29 | Immunochromatographic test paper for detecting fumonisin B1 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810992495.9A CN109085336B (en) | 2018-08-29 | 2018-08-29 | Immunochromatographic test paper for detecting fumonisin B1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109085336A true CN109085336A (en) | 2018-12-25 |
| CN109085336B CN109085336B (en) | 2021-03-02 |
Family
ID=64795066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810992495.9A Expired - Fee Related CN109085336B (en) | 2018-08-29 | 2018-08-29 | Immunochromatographic test paper for detecting fumonisin B1 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109085336B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109633151A (en) * | 2018-12-26 | 2019-04-16 | 西北农林科技大学 | A kind of Bacterium enteritidis detection method, test strips and application |
| CN110041922A (en) * | 2019-04-12 | 2019-07-23 | 冯翔宇 | A kind of carbon-based nano fluorescent material and preparation method thereof |
| CN113607940A (en) * | 2021-07-30 | 2021-11-05 | 大陌检测技术(云南)有限公司 | Quantum dot fluorescence immunochromatography detection method for drug detection |
| CN115232202A (en) * | 2022-08-09 | 2022-10-25 | 广州敏捷生物技术有限公司 | Fumonisin artificial antigen and preparation method and application thereof |
Citations (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008018716A1 (en) * | 2006-08-09 | 2008-02-14 | Korea Research Institute Of Bioscience And Biotechnology | Sillica capsules having nano-holes or nano-pores on their surfaces and method for preparing the same |
| WO2008141351A1 (en) * | 2007-05-21 | 2008-11-27 | Erber Aktiengesellschaft | Method for quantitatively determining analytes using a test element and test system and use thereof |
| CN101333436A (en) * | 2008-08-06 | 2008-12-31 | 湖南大学 | Multi-color optic-encoding siliceous skin nano-rods and method for preparing same |
| US20100012899A1 (en) * | 2008-07-17 | 2010-01-21 | Hyun-Sik Kim | Method of preparing metallic oxide phosphor |
| CN101661043A (en) * | 2009-09-27 | 2010-03-03 | 上海交通大学 | Method for detecting fumonisin by colloidal gold immunochromatographic test |
| CN101907556A (en) * | 2010-07-19 | 2010-12-08 | 湖南大学 | Method for detecting the colon bacillus by combining magnetic nanoparticle enrichment with bi-color flow cytometry |
| CN101913611A (en) * | 2010-03-17 | 2010-12-15 | 上海大学 | Method for preparing simple, convenient, size-controllable and mono-disperse nano silicon dioxide granules |
| CN102520179A (en) * | 2011-12-07 | 2012-06-27 | 上海交通大学 | Quantitative detection method of fumonisins B1 |
| JP2012240983A (en) * | 2011-05-23 | 2012-12-10 | National Institute Of Advanced Industrial Science & Technology | Surface modification material for immobilizing protein |
| CN103484111A (en) * | 2013-09-13 | 2014-01-01 | 中国科学院宁波材料技术与工程研究所 | Meso-porous silicon fluorescent material and manufacturing method |
| CN104031642A (en) * | 2014-06-24 | 2014-09-10 | 山西大学 | Fluorescence carbon quantum dots, and preparation method and application thereof |
| CN104140084A (en) * | 2014-08-01 | 2014-11-12 | 中国人民解放军国防科学技术大学 | Method for preparing carbon nitride quantum dots |
| CN105431436A (en) * | 2013-05-14 | 2016-03-23 | 内尔维阿诺医学科学有限公司 | Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| CN106153929A (en) * | 2015-04-01 | 2016-11-23 | 杨挥 | By test strips and the method for fluorescence immune chromatography technology for detection mycotoxin |
| CN106771213A (en) * | 2016-11-29 | 2017-05-31 | 百奥森（江苏）食品安全科技有限公司 | A kind of fumonisin detection method |
| CN106833629A (en) * | 2017-01-05 | 2017-06-13 | 东南大学 | A kind of Mitochondrially targeted fluorescent carbon point and its preparation method and application |
| CN107583600A (en) * | 2017-10-18 | 2018-01-16 | 上海纳米技术及应用国家工程研究中心有限公司 | Preparation method of improved silica hydrogel and products thereof and application |
| CN107915770A (en) * | 2016-10-11 | 2018-04-17 | 联宁（苏州）生物制药有限公司 | A kind of antibody drug conjugates intermediate and preparation method thereof |
-
2018
- 2018-08-29 CN CN201810992495.9A patent/CN109085336B/en not_active Expired - Fee Related
Patent Citations (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008018716A1 (en) * | 2006-08-09 | 2008-02-14 | Korea Research Institute Of Bioscience And Biotechnology | Sillica capsules having nano-holes or nano-pores on their surfaces and method for preparing the same |
| WO2008141351A1 (en) * | 2007-05-21 | 2008-11-27 | Erber Aktiengesellschaft | Method for quantitatively determining analytes using a test element and test system and use thereof |
| US20100012899A1 (en) * | 2008-07-17 | 2010-01-21 | Hyun-Sik Kim | Method of preparing metallic oxide phosphor |
| CN101333436A (en) * | 2008-08-06 | 2008-12-31 | 湖南大学 | Multi-color optic-encoding siliceous skin nano-rods and method for preparing same |
| CN101661043A (en) * | 2009-09-27 | 2010-03-03 | 上海交通大学 | Method for detecting fumonisin by colloidal gold immunochromatographic test |
| CN101913611A (en) * | 2010-03-17 | 2010-12-15 | 上海大学 | Method for preparing simple, convenient, size-controllable and mono-disperse nano silicon dioxide granules |
| CN101907556A (en) * | 2010-07-19 | 2010-12-08 | 湖南大学 | Method for detecting the colon bacillus by combining magnetic nanoparticle enrichment with bi-color flow cytometry |
| JP2012240983A (en) * | 2011-05-23 | 2012-12-10 | National Institute Of Advanced Industrial Science & Technology | Surface modification material for immobilizing protein |
| CN102520179A (en) * | 2011-12-07 | 2012-06-27 | 上海交通大学 | Quantitative detection method of fumonisins B1 |
| CN105431436A (en) * | 2013-05-14 | 2016-03-23 | 内尔维阿诺医学科学有限公司 | Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| CN103484111A (en) * | 2013-09-13 | 2014-01-01 | 中国科学院宁波材料技术与工程研究所 | Meso-porous silicon fluorescent material and manufacturing method |
| CN104031642A (en) * | 2014-06-24 | 2014-09-10 | 山西大学 | Fluorescence carbon quantum dots, and preparation method and application thereof |
| CN104140084A (en) * | 2014-08-01 | 2014-11-12 | 中国人民解放军国防科学技术大学 | Method for preparing carbon nitride quantum dots |
| CN106153929A (en) * | 2015-04-01 | 2016-11-23 | 杨挥 | By test strips and the method for fluorescence immune chromatography technology for detection mycotoxin |
| CN107915770A (en) * | 2016-10-11 | 2018-04-17 | 联宁（苏州）生物制药有限公司 | A kind of antibody drug conjugates intermediate and preparation method thereof |
| CN106771213A (en) * | 2016-11-29 | 2017-05-31 | 百奥森（江苏）食品安全科技有限公司 | A kind of fumonisin detection method |
| CN106833629A (en) * | 2017-01-05 | 2017-06-13 | 东南大学 | A kind of Mitochondrially targeted fluorescent carbon point and its preparation method and application |
| CN107583600A (en) * | 2017-10-18 | 2018-01-16 | 上海纳米技术及应用国家工程研究中心有限公司 | Preparation method of improved silica hydrogel and products thereof and application |
Non-Patent Citations (10)
| Title |
|---|
| DE-WEN ZHANG等: "Photoelectrochemical response of carbon dots (CDs) derived from chitosan and their use in electrochemical imaging", 《MATER. HORIZ.》 * |
| F.DINARDO等: "A fluorescent immunochromatographic strip test using Quantum Dots for fumonisins detection", 《TALANTA》 * |
| WEIJIAN LIU等: "Carbon dots surface engineering and applications", 《J. MATER. CHEM. B》 * |
| XIAOJUAN GONG等: "Facile synthesis of nitrogen-doped carbon dots for Fe3+ sensing and cellular imaging", 《ANALYTICA CHIMICA ACTA》 * |
| YUNHUA YANG等: "One-step synthesis of amino-functionalized fluorescent carbon nanoparticles by hydrothermal carbonization of chitosan", 《CHEM. COMMUN.》 * |
| 孙靖等: "掺杂碳量子点的二氧化硅纳米管的合成与表征", 《中国科技论文》 * |
| 李滋: "稀土铕配合物掺杂的功能化二氧化硅微球的制备与表征", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
| 石道飞等: "碳量子点的特性与合成方法", 《广东化工》 * |
| 陈建玲等: "伏马毒素B1时间分辨免疫荧光检测试剂盒的研制", 《癌变 畸变 突变》 * |
| 陈志燕等: "氮掺杂碳量子点荧光猝灭法检测水中Hg2+", 《分析科学学报》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109633151A (en) * | 2018-12-26 | 2019-04-16 | 西北农林科技大学 | A kind of Bacterium enteritidis detection method, test strips and application |
| CN110041922A (en) * | 2019-04-12 | 2019-07-23 | 冯翔宇 | A kind of carbon-based nano fluorescent material and preparation method thereof |
| CN113607940A (en) * | 2021-07-30 | 2021-11-05 | 大陌检测技术(云南)有限公司 | Quantum dot fluorescence immunochromatography detection method for drug detection |
| CN115232202A (en) * | 2022-08-09 | 2022-10-25 | 广州敏捷生物技术有限公司 | Fumonisin artificial antigen and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109085336B (en) | 2021-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109085336A (en) | A kind of immune chromatography test paper detecting fumonisins B1 | |
| CN108896766A (en) | A kind of immune chromatography test paper detecting vomitoxin | |
| CN105866419B (en) | A kind of fluorescence immune chromatography test paper for detecting vomitoxin | |
| CN109781980A (en) | African swine fever virus rapid detection card and its application | |
| CN105622695B (en) | The application of estriol haptens and antibody and its fast response transducer in the method for detection free estriol | |
| CN102866252B (en) | Immunochromatography test strip marked by phosphorescent silica nano particles and used for quantitatively detecting cimaterol and preparation method for immunochromatography test strip | |
| WO2022032983A1 (en) | Quantum dot microsphere immunochromatography test strip for detection of african swine fever virus mucous membrane siga antibody, and use thereof | |
| CN106075473B (en) | A kind of contrast agent and preparation method thereof being imaged for fluorescence-magnetic resonance bimodal target biology | |
| CN107748147B (en) | White luminous up-conversion nano-particles and test strip based on same and capable of simultaneously realizing detection of multi-component tumor markers | |
| CN104804082A (en) | Immunofluorescence detection test strip and preparation method thereof for rapid quantitative detection of porcine epidemic diarrhea viruses | |
| CN106905318A (en) | Amino tadalafil haptens, artificial antigen and preparation method thereof | |
| CN110441280A (en) | A kind of method of the double fluorescence system scale fluorescence probe in detecting tetracyclines of carbon dots-rhodamine B and Clenbuterol | |
| CN108469445A (en) | For the kit of the lanthanide fluoro nano-particle based on excitation of X-rays of cancer antigen content and preparation in no background detection blood | |
| CN108226509A (en) | The fluorescence immune chromatography detection method and Test paper of a kind of salmonella typhimurium | |
| CN105259354A (en) | Kit for detecting tuberculosis T cell release gamma-interferon and use method of kit | |
| CN105974109B (en) | A kind of fluorescence immune chromatography test paper for detecting ochratoxin A | |
| CN108982863A (en) | A kind of immune chromatography test paper detecting imidacloprid | |
| CN109293776A (en) | A kind of Fipronil binding proteins specific and its application | |
| CN106018795B (en) | A kind of fluorescence immune chromatography test paper for detecting aflatoxin B1 | |
| CN110372789A (en) | CDs/SiO2- SFTSV monoclonal antibody conjugate and its preparation method and application | |
| CN105974113A (en) | Sandwiched immunochromatographic test paper used for detecting Escherichia coli O157:H7 | |
| Xu et al. | Quantum dot-based immunochromatography test strip for rapid detection of campylobacter jejuni | |
| CN109061167A (en) | A kind of immune chromatography test paper detecting pyrethroid | |
| CN108982862A (en) | It is a kind of for detecting the immuno-chromatographic test paper strip and preparation method thereof of capsaicine in gutter oil | |
| CN109406786A (en) | A kind of immune chromatography test paper detecting acephatemet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210302 Termination date: 20210829 |